OraSure Technologies/ US68554V1089 /
17/05/2024 21:59:59 | Chg. -0.29 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
4.93USD | -5.56% | 20,121 Turnover: 99,864.75 |
-Bid Size: - | -Ask Size: - | 5.15 | 4.91 |
GlobeNewswire
22/04
OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th
GlobeNewswire
13/02
OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th
GlobeNewswire
04/01
OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Ge...
GlobeNewswire
19/12/2023
Aspira Women’s Health to Host R&D Day With Updates on the Development of the Company's Ovarian Cance...
GlobeNewswire
07/11/2023
OraSure Reports Q3 ‘23 Revenue of $89.2 Million; Core Revenue Grows 7% Year-over-Year
GlobeNewswire
23/10/2023
OraSure to Announce Third Quarter 2023 Financial Results and Host Earnings Call on November 7th
GlobeNewswire
11/09/2023
Aspira Women’s Health Announces Dr. Jody Berry as New Chief Scientific Officer
GlobeNewswire
29/03/2022
HOUSING WORKS & FOUNDING CHAIR JAMES HUNIFORD ANNOUNCE LINEUP OF TOP INTERIOR DESIGNERS FOR ANNUAL D...
GlobeNewswire
22/03/2022
OraSure Director Nancy Gagliano Selected to Serve as Interim Chief Executive Officer; Brings Extensi...
GlobeNewswire
23/02/2022
OraSure Technologies Reports 4Q21 Revenue of $63.6 Million; InteliSwab® Production Scales Up
GlobeNewswire
16/02/2022
OraSure Technologies, Inc. 2021 Fourth Quarter Earnings Conference Call Wednesday, February 23, 2022...
GlobeNewswire
31/01/2022
InteliSwab® COVID-19 Rapid Tests Receive U.S. FDA Authorization for Pediatric Use and Company Launch...
GlobeNewswire
13/01/2022
InteliSwab® COVID-19 Rapid Tests Detect Omicron at Same Level as Other Variants
GlobeNewswire
30/11/2021
OraSure Technologies Remains Committed to the Global Fight Against HIV 40 Years After the Discovery ...